These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9089338

  • 1. Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptors.
    Shiosaki K, Lin CW, Kopecka H, Bianchi B, Miller T, Stashko M, Witte D.
    J Med Chem; 1997 Mar 28; 40(7):1169-72. PubMed ID: 9089338
    [Abstract] [Full Text] [Related]

  • 2. Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-a receptor agonists.
    Shiosaki K, Lin CW, Kopecka H, Tufano MD, Bianchi BR, Miller TR, Witte DG, Nadzan AM.
    J Med Chem; 1991 Sep 28; 34(9):2837-42. PubMed ID: 1716682
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Conformational analysis of CCK-B agonists using 1H-NMR and restrained molecular dynamics: comparison of biologically active Boc-Trp-(N-Me) Nle-Asp-Phe-NH2 and inactive Boc-Trp-(N-Me)Phe-Asp-Phe-NH2.
    Goudreau N, Weng JH, Roques BP.
    Biopolymers; 1994 Feb 28; 34(2):155-69. PubMed ID: 8142585
    [Abstract] [Full Text] [Related]

  • 5. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP.
    J Med Chem; 1997 Feb 28; 40(5):647-58. PubMed ID: 9057851
    [Abstract] [Full Text] [Related]

  • 6. Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.
    Shiosaki K, Lin CW, Kopecka H, Craig RA, Bianchi BR, Miller TR, Witte DG, Stashko M, Nadzan AM.
    J Med Chem; 1992 May 29; 35(11):2007-14. PubMed ID: 1375964
    [Abstract] [Full Text] [Related]

  • 7. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    Lin CW, Shiosaki K, Miller TR, Witte DG, Bianchi BR, Wolfram CA, Kopecka H, Craig R, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1991 Mar 29; 39(3):346-51. PubMed ID: 1706470
    [Abstract] [Full Text] [Related]

  • 8. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH.
    Cancer Res; 1993 Sep 01; 53(17):3925-9. PubMed ID: 8358719
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue.
    Bennett MJ, Nikkel AL, Bianchi BR, Miller TR, Bednarz L, Witte DG, Stashko M, Wang SS, Gore PA, Asin KE.
    J Med Chem; 1994 May 27; 37(11):1569-71. PubMed ID: 8201591
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM, Béhé M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W.
    Clin Cancer Res; 1999 Oct 27; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623).
    Sugg EE, Kimery MJ, Ding JM, Kenakin DC, Miller LJ, Queen KL, Rimele TJ.
    J Med Chem; 1995 Jan 06; 38(1):207-11. PubMed ID: 7837233
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Conformational-functional relationships of tetragastrin analogs].
    Nikiforovich GV, Liepinia IT, Tseĭtin VM, Shenderovich MD, Galaktionov SG.
    Bioorg Khim; 1991 May 06; 17(5):626-36. PubMed ID: 1768290
    [Abstract] [Full Text] [Related]

  • 17. Alternate drug delivery routes for A-71623, a potent cholecystokinin-A receptor agonist tetrapeptide.
    Cannon JB, Adjei LA, Lu MY, Garren K.
    J Drug Target; 1996 May 06; 4(2):69-78. PubMed ID: 8894966
    [Abstract] [Full Text] [Related]

  • 18. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C, Nikiforovich G, Sharma SD, Yang YK, Dickinson C, Hruby VJ, Gantz I.
    J Med Chem; 1997 May 23; 40(11):1738-48. PubMed ID: 9171884
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.